Prevalence of SGLT2i and GLP1RA Use among US Adults with Type 2 Diabetes

被引：0
|
作者：
Limonte, Christine
Hall, Yoshio
Trikudanathan, Subbulaxmi
Tuttle, Katherine R.
Hirsch, Irl B.
De Boer, Ian
Zelnick, Leila
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1216-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1216-P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
    Ritsinger, Viveca
    Avander, Kamila
    Lagerqvist, Bo
    Lundman, Pia
    Norhammar, Anna
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [32] Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
    Nathorn Chaiyakunapruk
    Xi Tan
    Yuanjie Liang
    Mico Guevarra
    Lin Xie
    Alice Y. Y. Cheng
    Cardiovascular Diabetology, 24 (1)
  • [33] Glycaemic control and beta cell function in type 2 diabetes on SGLT2i and GLP-1RA combination therapy
    Martinez, R.
    Al-Jobory, H.
    Adams, J.
    Chavez-Velasquez, A.
    Triplitt, C.
    DeFronzo, R. A.
    Cersosimo, E.
    DIABETOLOGIA, 2017, 60 : S408 - S409
  • [34] Expanding the Use of SGLT2i in Diabetes Beyond Type 2
    Giaccari, Andrea
    DIABETES CARE, 2024, 47 (01) : 50 - 51
  • [35] Anticipating the Impact of 2019 Guidelines: Use of SGLT2i and GLP-1RA in Patients with Diabetes and Cardiovascular Disease
    Rattelman, Cori R.
    Ciemins, Elizabeth L.
    Cuddeback, John K.
    DIABETES, 2019, 68
  • [36] Different Effect on UACR According to Predetermined Treatment Schedule Groups (GLP1RA or SGLT2i) Therapy in T2DM
    Carretero Gomez, Juana
    Ena, Javier
    Miguel Segui-Ripoll, Jose
    Javier Carrasco-Sanchez, Francisco
    Arevalo Lorido, Jose Carlos
    Suarez Tembra, Manuel
    Manuel Varela, Jose
    Gomez-Huelgas, Ricardo
    DIABETES, 2020, 69
  • [37] Initiation of SGLT2i Versus GLP1-RA and the Risk of Chronic Kidney Disease in Persons with Type 2 Diabetes Mellitus
    Jensen, Simon K.
    Heide-Jorgensen, Uffe
    Andersen, Ina T.
    Thomsen, Reimar W. W.
    Christiansen, Christian Fynbo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 87 - 87
  • [38] GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
    Pablo, Aschner
    Evelyn, Blanc
    Claudia, Folino
    Yanina, Morosan A.
    CURRENT HYPERTENSION REVIEWS, 2021, 17 (02) : 149 - 158
  • [39] Extraglycemic Effects of SGLT2i/GLP1-ra: A Topic Update
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 826 - 827
  • [40] GLP1RA Use and Risk of Pancreatitis and Biliary Disease in Adults with Type 2 Diabetes and Low to Moderate CV Risk
    Paik, Julie M.
    Tesfaye, Helen
    Cromer, Sara Jane
    Dicesare, Elyse O.
    Alix, Caroline
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2024, 73
12345